Galapagos signs agreement to transfer Jyseleca® business to Alfasigma
GlobeNewswire
· *Transaction expected to close in the first quarter of 2024, subject to customary closing conditions*
· *Michele Manto,..
· *Transaction expected to close in the first quarter of 2024, subject to customary closing conditions*
· *Michele Manto,..
· Galapagos to transfer drug discovery and research activities in Romainville, France to NovAliX, a drug-discovery focused..
March 28, 2022
*Amsterdam, the Netherlands –* Royal Philips (NYSE: PHG, AEX: PHIA) today convenes the Annual General..